Download full report with analyst certification and important disclosures
Aug 7 2020, 06:45 IST/BST
Uniphar
Expanding access
- Sectors : Pharma and healthcare
- Companies : Uniphar
DAVY VIEW
The Uniphar investment case is rapidly transitioning from ‘value’ to ‘growth’. A key part of the growth agenda is driven by Product Access, in particular Expanded Access Programs (EAPs). Uniphar has already positioned itself as a leading partner to biopharma companies for EAPs and has ambitions to be the global market leader. In this report, we detail the structural drivers underpinning growth in this market, argue that there is an increasing need for outsourcing to specialist players and look at Uniphar’s current, and potential future, market positioning.
